DSSTox_CID_3413

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

127 API Suppliers, 74 USDMF, 29 CEP/COS, 10 JDMF, 8 EU WC, 27 KDMF, 19 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1191 Drugs in Development

1191 Drugs in Development

INTERMEDIATES

11 Intermediate Suppliers

11 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

365 FDF Dossiers, 24 FDA Orange Book, 130 Europe, 5 Canada, 12 Australia, 131 South Africa, 63 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 6MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INTRAVENOUS - 100MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 2 BASF, 1 CD Formulation, 1 Corel Pharma Chem, 1 Nanjing Bold Chemical

EXCIPIENTS BY APPLICATIONS

3 Solubilizers, 3 Parenteral, 2 Emulsifying Agents, 2 Thickeners and Stabilizers, 2 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Topical, 1 Taste Masking, 1 Granulation